Clinical Trial Update: Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC

View source ↗

Summary

A clinical trial evaluating pembrolizumab in combination with double platinum-based chemotherapy for potentially resectable non-small cell lung cancer; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING